Repligen Corporation (RGEN)
NASDAQ: RGEN
· Real-Time Price · USD
126.08
-1.44 (-1.13%)
At close: Jun 16, 2025, 3:59 PM
126.09
0.01%
After-hours: Jun 16, 2025, 04:10 PM EDT
-1.13% (1D)
| Bid | 120 |
| Market Cap | 7.08B |
| Revenue (ttm) | 645.66M |
| Net Income (ttm) | -25.37M |
| EPS (ttm) | -0.42 |
| PE Ratio (ttm) | -300.19 |
| Forward PE | 60.46 |
| Analyst | Buy |
| Ask | 136.55 |
| Volume | 947,517 |
| Avg. Volume (20D) | 826,984 |
| Open | 127.72 |
| Previous Close | 127.52 |
| Day's Range | 120.69 - 127.72 |
| 52-Week Range | 102.97 - 182.52 |
| Beta | 1.11 |
About RGEN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGEN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-5.54%
Repligen shares are trading lower. Evercore ISI Gr...
Unlock content with
Pro Subscription
3 months ago
+7.92%
Repligen shares are trading higher after the company reported better-than-expected Q4 financial results
19 hours ago · businesswire.com
908 Devices Appoints Christopher D. Brown to its Board of DirectorsBOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, ...
